| TX | HB845 | Intro
Prefile | Relating to the authority of pharmacists to furnish certain medications.
[Detail][Text][Discuss] | 2024-11-12
Filed |
| TX | HB1027 | Intro
Prefile | Relating to the provision of telepharmacy services.
[Detail][Text][Discuss] | 2024-11-12
Filed |
| TX | HB4123 | Pass | Relating to access to and use of certain criminal history record information.
[Detail][Text][Discuss] | 2023-06-13
Effective immediately |
| TX | HB4332 | Pass | Relating to the redistribution of donated prepackaged prescription drugs.
[Detail][Text][Discuss] | 2023-06-12
Effective on 9/1/23 |
| TX | HB1105 | Engross
Sine Die | Relating to preventative health care and public health, including prohibited immunization and face-covering requirements, private business or school closures, and the ordering and administration of immunizations by a pharmacist.
[Detail][Text][Discuss] | 2023-05-26
House appoints conferees-reported |
| TX | HB1390 | Engross
Sine Die | Relating to telemedicine medical services and telehealth services covered by certain health benefit plans or provided by a pharmacist.
[Detail][Text][Discuss] | 2023-05-11
To Senate Health & Human Services Committee |
| TX | HB2767 | Engross
Sine Die | Relating to the sharing of controlled substance prescription monitoring information between the Texas State Board of Pharmacy and the Health and Human Services Commission for the state Medicaid program.
[Detail][Text][Discuss] | 2023-05-09
To Senate Health & Human Services Committee |
| TX | HB1570 | Intro
Sine Die | Relating to the sunset review process and certain governmental entities subject to that process.
[Detail][Text][Discuss] | 2023-05-08
Considered in Calendars |
| TX | HB1240 | Intro
Sine Die | Relating to the authority of a physician to provide and dispense and to delegate authority to provide and dispense certain drugs.
[Detail][Text][Discuss] | 2023-05-06
Committee report sent to Calendars |
| TX | HB2088 | Engross
Sine Die | Relating to the regulation of the practice of pharmacy.
[Detail][Text][Discuss] | 2023-05-05
To Senate Health & Human Services Committee |
| TX | HB2462 | Intro
Sine Die | Relating to disclosure of certain complaint and investigation information by the Texas State Board of Pharmacy to the United States Food and Drug Administration.
[Detail][Text][Discuss] | 2023-04-24
To House Public Health Committee |
| TX | HB594 | Intro
Sine Die | Relating to the provision of telepharmacy services.
[Detail][Text][Discuss] | 2023-04-17
To House Public Health Committee |
| TX | HB1373 | Intro
Sine Die | Relating to a pilot program for the safe disposal of controlled substance prescription drugs.
[Detail][Text][Discuss] | 2023-04-17
To House Public Health Committee |
| TX | HB2079 | Intro
Sine Die | Relating to the authority of pharmacists to order and furnish certain prescription drugs.
[Detail][Text][Discuss] | 2023-04-17
To House Public Health Committee |
| TX | HB5129 | Intro
Sine Die | Relating to the delegation to a pharmacy technician of a pharmacist's authority to administer an immunization or vaccine.
[Detail][Text][Discuss] | 2023-03-24
To House Public Health Committee |
| TX | HB5298 | Intro
Sine Die | Relating to a pilot program under which lockable, tamper-evident containers are used by participating pharmacies when dispensing schedule II controlled substances.
[Detail][Text][Discuss] | 2023-03-24
To House Public Health Committee |
| TX | HB4581 | Intro
Sine Die | Relating to the regulation of the practice of pharmacy.
[Detail][Text][Discuss] | 2023-03-22
To House Public Health Committee |
| TX | HB4341 | Intro
Sine Die | Relating to promoting, prescribing, administering, or dispensing prescription drugs for off-label use.
[Detail][Text][Discuss] | 2023-03-21
To House Public Health Committee |
| TX | HB3152 | Intro
Sine Die | Relating to the identification of the country of manufacture on the label for a prescription drug or biological product.
[Detail][Text][Discuss] | 2023-03-15
To House Public Health Committee |
| TX | HB2853 | Intro
Sine Die | Relating to an order issued by the commissioner of state health services to authorize emergency contraceptives.
[Detail][Text][Discuss] | 2023-03-14
To House Public Health Committee |
| TX | HB3082 | Intro
Sine Die | Relating to a pharmacy, pharmacist, or pharmacy technician decision to not dispense or sell a drug according to religious belief or moral conviction.
[Detail][Text][Discuss] | 2023-03-14
To House Public Health Committee |
| TX | HB2078 | Intro
Sine Die | Relating to the authority of a physician to provide and dispense and to delegate authority to provide and dispense certain drugs.
[Detail][Text][Discuss] | 2023-03-08
To House Public Health Committee |
| TX | HB972 | Intro
Sine Die | Relating to warning labels for opioid prescription drugs.
[Detail][Text][Discuss] | 2023-03-02
To House Public Health Committee |
| TX | HB1050 | Intro
Sine Die | Relating to the authority of pharmacists to dispense self-administered hormonal contraceptives.
[Detail][Text][Discuss] | 2023-03-02
To House Public Health Committee |
| TX | HB815 | Intro
Sine Die | Relating to distinctive packaging for opioid prescription drugs.
[Detail][Text][Discuss] | 2023-03-01
To House Public Health Committee |
| TX | HB816 | Intro
Sine Die | Relating to warning labels for opioid prescription drugs.
[Detail][Text][Discuss] | 2023-03-01
To House Public Health Committee |
| TX | HB814 | Intro
Sine Die | Relating to an acknowledgment on receipt of an opioid prescription drug.
[Detail][Text][Discuss] | 2023-03-01
To House Public Health Committee |
| TX | HB235 | Intro
Sine Die | Relating to the authority of pharmacists to furnish certain medications.
[Detail][Text][Discuss] | 2023-02-23
To House Public Health Committee |
